Selection of potential therapeutic bacteriophages that lyse a CTX-M-15 extended spectrum β-lactamase producing Salmonella enterica serovar typhi strain from the democratic republic of the Congo

Elene Kakabadze, Khatuna Makalatia, Nino Grdzelishvili, Nata Bakuradze, Marina Goderdzishvili, Ia Kusradze, Marie France Phoba, Octavie Lunguya, Cédric Lood, Rob Lavigne, Jan Jacobs, Stijn Deborggraeve, Tessa De Block, Sandra Van Puyvelde, David Lee, Aidan Coffey, Anahit Sedrakyan, Patrick Soentjens, Daniel De Vos, Jean Paul PirnayNina Chanishvili

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Recently, a Salmonella Typhi isolate producing CTX-M-15 extended spectrum β-lactamase (ESBL) and with decreased ciprofloxacin susceptibility was isolated in the Democratic Republic of the Congo. We have selected bacteriophages that show strong lytic activity against this isolate and have potential for phage-based treatment of S. Typhi, and Salmonella in general.

    Original languageEnglish
    Article number172
    JournalViruses
    Volume10
    Issue number4
    DOIs
    Publication statusPublished - Apr 2018

    Keywords

    • Bacteriophages
    • Democratic republic of the Congo
    • Extended-spectrum beta lactamases (ESBL)
    • Salmonella typhi
    • Typhoid fever

    Fingerprint

    Dive into the research topics of 'Selection of potential therapeutic bacteriophages that lyse a CTX-M-15 extended spectrum β-lactamase producing Salmonella enterica serovar typhi strain from the democratic republic of the Congo'. Together they form a unique fingerprint.

    Cite this